AUTHOR=Fu Tengyue , Mao Chuxiao , Chen Zhuming , Huang Yuxiang , Li Houlin , Wang Chunhua , Liu Jie , Li Shenyu , Lin Famu TITLE=Disease characteristics and clinical specific survival prediction of spinal ependymoma: a genetic and population-based study JOURNAL=Frontiers in Neurology VOLUME=15 YEAR=2024 URL=https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2024.1454061 DOI=10.3389/fneur.2024.1454061 ISSN=1664-2295 ABSTRACT=Background

Spinal Ependymoma (SP-EP) is the most commonly occurring tumor affecting the spinal cord. Prompt diagnosis and treatment can significantly enhance prognostic outcomes for patients. In this study, we conducted a comprehensive analysis of RNA sequencing data, along with associated clinical information, from patients diagnosed with SP-EP. The aim was to identify key genes that are characteristic of the disease and develop a survival-related nomogram.

Methods

We first accessed the Gene Expression Integrated Database (GEO) to acquire the microarray dataset pertaining to SP-EP. This dataset was then processed to identify differentially expressed genes (DEGs) between SP-EP samples and normal controls. Furthermore, machine learning techniques and the CIBERSORT algorithm were employed to extract immune characteristic genes specific to SP-EP patients, thereby enhancing the characterization of target genes. Next, we retrieved comprehensive information on patients diagnosed with SP-EP between 2000 and 2020 from the Surveillance, Epidemiology, and End Results Database (SEER). Using this data, we screened for predictive factors that have a significant impact on patient outcomes. A nomogram was constructed to visualize the predicted overall survival (OS) rates of these patients at 3, 5, and 8 years post-diagnosis. Finally, to assess the reliability and clinical utility of our predictive model, we evaluated it using various metrics including the consistency index (C-index), time-dependent receiver operating characteristic (ROC) curves, area under the curve (AUC), calibration curves, and decision curve analysis (DCA).

Results

A total of 5,151 DEGs were identified between the SP-EP sample and the normal sample. Analysis of Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways revealed that these DEGs were primarily involved in cellular processes, including cell cycle regulation and cell sensitivity mechanisms. Furthermore, immune infiltration analysis was utilized to identify the core gene CELF4. Regarding the survival rates of patients with SP-EP, the 3-year, 5-year, and 8-year survival rates were 72.5, 57.0, and 40.8%, respectively. Diagnostic age (p < 0.001), gender (p < 0.001), and surgical approach (p < 0.005) were identified as independent prognostic factors for OS. Additionally, a nomogram model was constructed based on these prognostic factors, demonstrating good consistency between predicted and actual results in the study’s validation process. Notably, the study also demonstrated that more extensive surgical resection could extend patients’ OS.

Conclusion

Through bioinformatics analysis of microarray datasets, we identified CELF4 as a central gene associated with immune infiltration among DEGs. Previous studies have demonstrated that CELF4 may play a pivotal role in the pathogenesis of SP-EP. Furthermore, this study developed and validated a prognostic prediction model in the form of a nomogram utilizing the SEER database, enabling clinicians to accurately assess treatment risks and benefits, thereby enhancing personalized therapeutic strategies and prognosis predictions.